COMP <GO>
DVA vs PGNY // EV/EBITDA & P/E VALUATION
DaVita Inc. (NYSE) VS. Progyny Inc. (NASDAQ) • 15-METRIC TALLY: DVA 8
— PGNY 3
▲ EV/EBITDA & P/E VALUATION LEADER: DVA
LAST: $193.31 (+5.10%) • MKT CAP: $12.33B
valuation
7.3x
LAST: $28.40 (+1.90%) • MKT CAP: $2.18B
valuation
20.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DVA VS. PGNY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DVA | PGNY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 23.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.20% | 16.70% | +12.50 | DVA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.3x | 20.5x | -13.20 | DVA | /valuation <GO> |
| Free Cash Flow Yield | 10.63% | 8.80% | +1.83 | DVA | /fcf-yield <GO> |
| Operating Margin | 15.00% | 6.60% | +8.40 | DVA | /operating-margins <GO> |
| Net Profit Margin | 7.90% | 4.50% | +3.40 | DVA | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 10.40% | -3.90 | PGNY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.66 | 8.84 | -7.18 | PGNY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | DVA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 62.0 | -2.72 | PGNY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.6x | 34.6x | -24.00 | DVA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.33B | $2.18B | $10.15B | DVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DVA REV | PGNY REV | DVA GROSS % | PGNY GROSS % | DVA FCF | PGNY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.64B | $1.29B | — | 23.6% | $1.31B | $191.8M |
| FY 2024 | $12.82B | $1.17B | — | 21.7% | $1.47B | $173.7M |
| FY 2023 | $12.14B | $1.09B | — | — | $1.51B | $188.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DVA // BETA 0.95
PGNY // BETA —